MX2019014935A - Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. - Google Patents
Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos.Info
- Publication number
- MX2019014935A MX2019014935A MX2019014935A MX2019014935A MX2019014935A MX 2019014935 A MX2019014935 A MX 2019014935A MX 2019014935 A MX2019014935 A MX 2019014935A MX 2019014935 A MX2019014935 A MX 2019014935A MX 2019014935 A MX2019014935 A MX 2019014935A
- Authority
- MX
- Mexico
- Prior art keywords
- muscarinic antagonists
- horses
- treatment
- airway disease
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
- A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2250/00—Specially adapted for animals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere al campo de la medicina, en particular al campo de la medicina veterinaria. La invención se refiere, específicamente, a antagonistas muscarínicos (incluyendo antagonistas muscarínicos de larga acción (LAMAs) para el tratamiento de enfermedades de las vías respiratorias tales como la enfermedad pulmonar, preferiblemente la obstrucción recurrente de las vías respiratorias (RAO), enfermedad pulmonar obstructiva asociada al pasto del verano (SPAOPD) y la enfermedad inflamatoria de las vías respiratorias (IAD) en animales, preferiblemente equinos tales como caballos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14172925 | 2014-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019014935A true MX2019014935A (es) | 2020-02-13 |
Family
ID=50972546
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016016720A MX370430B (es) | 2014-06-18 | 2015-06-15 | Antagonistas muscarínicos y sus combinaciones para el tratamiento de enfermedades de las vías respiratorias en caballos. |
MX2019014935A MX2019014935A (es) | 2014-06-18 | 2016-12-15 | Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016016720A MX370430B (es) | 2014-06-18 | 2015-06-15 | Antagonistas muscarínicos y sus combinaciones para el tratamiento de enfermedades de las vías respiratorias en caballos. |
Country Status (17)
Country | Link |
---|---|
US (3) | US9474747B2 (es) |
EP (2) | EP3157522B1 (es) |
KR (1) | KR102618119B1 (es) |
AU (2) | AU2015276310B2 (es) |
CA (1) | CA2952701C (es) |
CY (1) | CY1122335T1 (es) |
DK (1) | DK3157522T3 (es) |
ES (1) | ES2759247T3 (es) |
HR (1) | HRP20192010T1 (es) |
HU (1) | HUE051527T2 (es) |
LT (1) | LT3157522T (es) |
MX (2) | MX370430B (es) |
PL (1) | PL3157522T3 (es) |
PT (1) | PT3157522T (es) |
RS (1) | RS59613B1 (es) |
SI (1) | SI3157522T1 (es) |
WO (1) | WO2015193213A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ706573A (en) | 2012-12-21 | 2019-11-29 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
LT2934544T (lt) | 2012-12-21 | 2019-02-25 | Boehringer Ingelheim Vetmedica Gmbh | Farmacinė kompozicija, apimanti ciklezonidą |
KR102618119B1 (ko) | 2014-06-18 | 2023-12-27 | 베링거잉겔하임베트메디카게엠베하 | 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물 |
CN111840256A (zh) * | 2019-04-29 | 2020-10-30 | 上海谷森医药有限公司 | 一种雾化吸入剂及其制备方法 |
CN112752572B (zh) | 2019-05-23 | 2022-02-22 | 广州谷森制药有限公司 | 含有三苯乙酸维兰特罗和芜地溴铵的可吸入溶液组合物 |
WO2021262648A1 (en) * | 2020-06-23 | 2021-12-30 | Anovent Pharmaceutical (U.S.), Llc | Preparation of a pharmaceutical composition of olodaterol and budesonide |
AU2021314977A1 (en) | 2020-07-31 | 2023-03-02 | Chemo Research, S.L. | Combination therapy for inhalation administration |
WO2022073009A1 (en) | 2020-09-29 | 2022-04-07 | iPharma Labs, Inc. | Liquid formulations of indacaterol |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5954049A (en) | 1991-10-15 | 1999-09-21 | Trudell Medical Limited | Equine mask with MDI adapter |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
US5823179A (en) * | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
US6264923B1 (en) | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
DE10050994A1 (de) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
US6706726B2 (en) | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
DE10062712A1 (de) | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
US6904908B2 (en) * | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
DE10237739A1 (de) * | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
WO2004023984A2 (en) * | 2002-09-13 | 2004-03-25 | Smith C Steven | Novel composition and method for treatment of upper respiratory conditions |
CA2525943A1 (en) | 2003-05-22 | 2004-12-02 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
US20050020692A1 (en) * | 2003-07-24 | 2005-01-27 | Ciofalo Vincent B. | Treatment of heaves |
CA2538419C (en) | 2003-09-16 | 2012-07-03 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases |
PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
WO2005102354A1 (en) | 2004-04-20 | 2005-11-03 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
EP1763344A1 (en) | 2004-06-29 | 2007-03-21 | Boehringer Ingelheim International GmbH | Medicaments for inhalation comprising steroids and an anticholinergic |
DE102004056579A1 (de) * | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid |
US20070028923A1 (en) | 2005-08-08 | 2007-02-08 | Patrick Souris | Tip-laryngeal airway |
UY30543A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
UY30542A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
WO2010049280A2 (de) | 2008-10-30 | 2010-05-06 | Siemens Aktiengesellschaft | Verfahren zur einstellung einer auslaufdicke eines eine mehrgerüstige walzstrasse durchlaufenden walzguts, steuer- und/oder regeleinrichtung und walzanlage |
US8815258B2 (en) * | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
US9084660B2 (en) * | 2009-06-25 | 2015-07-21 | Boehringer Ingelheim Vetmedica Gmbh | Inhaler |
US20150202297A1 (en) * | 2012-07-05 | 2015-07-23 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose and a ternary component |
US20150202148A1 (en) * | 2012-07-05 | 2015-07-23 | Arven llac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose |
WO2014016548A2 (en) * | 2012-07-27 | 2014-01-30 | Cipla Limited | Pharmaceutical composition |
US9539408B2 (en) * | 2012-10-31 | 2017-01-10 | Trudell Medical International | Nebulizer apparatus |
LT2934544T (lt) * | 2012-12-21 | 2019-02-25 | Boehringer Ingelheim Vetmedica Gmbh | Farmacinė kompozicija, apimanti ciklezonidą |
NZ706573A (en) | 2012-12-21 | 2019-11-29 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
CA2913811C (en) * | 2013-08-20 | 2022-06-07 | Boehringer Ingelheim Vetmedica Gmbh | Inhaler |
CA3129707C (en) * | 2013-08-20 | 2023-04-25 | Boehringer Ingelheim Vetmedica Gmbh | Inhaler |
KR102618119B1 (ko) | 2014-06-18 | 2023-12-27 | 베링거잉겔하임베트메디카게엠베하 | 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물 |
-
2015
- 2015-06-15 KR KR1020177001472A patent/KR102618119B1/ko active IP Right Grant
- 2015-06-15 MX MX2016016720A patent/MX370430B/es active IP Right Grant
- 2015-06-15 ES ES15728025T patent/ES2759247T3/es active Active
- 2015-06-15 PL PL15728025T patent/PL3157522T3/pl unknown
- 2015-06-15 HU HUE15728025A patent/HUE051527T2/hu unknown
- 2015-06-15 SI SI201531016T patent/SI3157522T1/sl unknown
- 2015-06-15 WO PCT/EP2015/063265 patent/WO2015193213A1/en active Application Filing
- 2015-06-15 EP EP15728025.6A patent/EP3157522B1/en active Active
- 2015-06-15 PT PT157280256T patent/PT3157522T/pt unknown
- 2015-06-15 AU AU2015276310A patent/AU2015276310B2/en active Active
- 2015-06-15 LT LT15728025T patent/LT3157522T/lt unknown
- 2015-06-15 RS RS20191483A patent/RS59613B1/sr unknown
- 2015-06-15 CA CA2952701A patent/CA2952701C/en active Active
- 2015-06-15 DK DK15728025T patent/DK3157522T3/da active
- 2015-06-15 EP EP19192103.0A patent/EP3603640A1/en active Pending
- 2015-06-16 US US14/740,582 patent/US9474747B2/en active Active
-
2016
- 2016-09-23 US US15/274,259 patent/US10342789B2/en active Active
- 2016-12-15 MX MX2019014935A patent/MX2019014935A/es unknown
-
2019
- 2019-05-08 US US16/406,918 patent/US10682345B2/en active Active
- 2019-11-06 HR HRP20192010TT patent/HRP20192010T1/hr unknown
- 2019-12-02 CY CY20191101258T patent/CY1122335T1/el unknown
-
2020
- 2020-04-06 AU AU2020202402A patent/AU2020202402B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20150366855A1 (en) | 2015-12-24 |
WO2015193213A1 (en) | 2015-12-23 |
US10682345B2 (en) | 2020-06-16 |
PL3157522T3 (pl) | 2020-03-31 |
EP3603640A1 (en) | 2020-02-05 |
LT3157522T (lt) | 2019-11-25 |
AU2015276310A1 (en) | 2016-12-08 |
AU2020202402B2 (en) | 2021-05-27 |
US9474747B2 (en) | 2016-10-25 |
KR102618119B1 (ko) | 2023-12-27 |
CY1122335T1 (el) | 2021-01-27 |
SI3157522T1 (sl) | 2020-01-31 |
US20170007593A1 (en) | 2017-01-12 |
DK3157522T3 (da) | 2019-12-09 |
MX2016016720A (es) | 2017-04-13 |
RS59613B1 (sr) | 2020-01-31 |
CA2952701C (en) | 2023-09-19 |
CA2952701A1 (en) | 2015-12-23 |
US20190262329A1 (en) | 2019-08-29 |
AU2015276310B2 (en) | 2020-01-16 |
AU2020202402A1 (en) | 2020-04-30 |
HUE051527T2 (hu) | 2021-03-01 |
PT3157522T (pt) | 2019-12-13 |
ES2759247T3 (es) | 2020-05-08 |
EP3157522B1 (en) | 2019-09-04 |
KR20170016986A (ko) | 2017-02-14 |
EP3157522A1 (en) | 2017-04-26 |
US10342789B2 (en) | 2019-07-09 |
HRP20192010T1 (hr) | 2020-02-07 |
MX370430B (es) | 2019-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019014935A (es) | Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos. | |
HK1246600B (zh) | 使用動物飼料的寡糖組合物以及其製造方法 | |
ZA201608077B (en) | Combination, composition, and method of administering the combination or composition to animals | |
MX2021007268A (es) | Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas. | |
SG10201903823QA (en) | Methods and compositions relating to microbial treatment and diagnosis of disorders | |
EA201790528A1 (ru) | Дигидропирролопиридиновые ингибиторы ror-гамма | |
EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
WO2014151456A3 (en) | Treatment of inflammatory diseases | |
MX2017009417A (es) | Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas. | |
IN2015DN02894A (es) | ||
EA201890449A1 (ru) | Фумагиллиновые гетероциклические соединения и способы их получения и применения | |
EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
WO2016011049A3 (en) | Compositions and methods for disease treatment using nanoparticle delivered compounds | |
MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
FR3022139B1 (fr) | Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee | |
MX2017001293A (es) | Metodos y composiciones para diagnosticar y tratar trastornos inflamatorios del intestino. | |
EA201790020A1 (ru) | Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний | |
WO2015003049A3 (en) | Compositions and methods to treat inflammatory joint disease | |
WO2016083315A8 (en) | Use of ox1r antagonists for the treatment of inflammatory bowel diseases | |
MX2017009452A (es) | Agentes de imagenologia para tomografia de emision de positrones (pet). | |
AU2014353885A8 (en) | Prevention and treatment of toxicosis | |
IN2013MU03429A (es) | ||
MX2015012393A (es) | Derivados oxindol con un sustituyente oxetano y uso de los mismos para tratar enfermedades relacionadas con la vasopresina. | |
UA108238C2 (xx) | Антибактеріальна композиція |